Filing Manager
CRCM LP
Reporting Manager
CRCM LP
Symbol
BNR
Shares outstanding
9,041,375 shares
Disclosed Ownership
486,426 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
19 Dec 2025, 18:00:45 UTC
Date of event
16 Dec 2025
Next filing
13 May 2026

Quoteable Key Fact

"CRCM LP disclosed 5.4% ownership in Burning Rock Biotech Ltd. American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) on 16 Dec 2025."

Quick Takeaways

  • CRCM LP filed SCHEDULE 13G for Burning Rock Biotech Ltd. American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR).
  • Disclosed ownership: 5.4%.
  • Date of event: 16 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 19 Dec 2025, 18:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
CRCM INSTITUTIONAL MASTER FUND (BVI), LTD. 5.2% 465,000 0 465,000 /s/ Chun R. Ding CRCM INSTITUTIONAL MASTER FUND (BVI), LTD.
CRCM LP 5.4% 486,426 0 486,426 /s/ Chun R. Ding CRCM LP
CRCM LLC 5.4% 486,426 0 486,426 /s/ Chun R. Ding CRCM LLC
Ding Chun R 5.4% 486,426 0 486,426 /s/ Chun R. Ding DING CHUN R
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .